Hepatitis Monthly

Published by: Kowsar

Hepatitis C Virus Capsid Protein and Intracellular Lipids Interplay and itsAssociation With Hepatic Steatosis

Muhammad Sohail Afzal 1 , 2 , * , Najam Us Sahar Sadaf Zaidi 2 , Jean Dubuisson 1 and Yves Rouille 1
Authors Information
1 Center for Infection and Immunity of Lille (CIIL), Institut Pasteur de Lille, Univ Lille Nord de France, Lille, France
2 Atta ur Rahman School of Applied Biosciences, National University of Sciences and Technology, H-12 Islamabad, Pakistan
Article information
  • Hepatitis Monthly: August 01, 2014, 14 (8); e17812
  • Published Online: August 11, 2014
  • Article Type: Research Article
  • Received: January 24, 2014
  • Revised: March 9, 2014
  • Accepted: May 8, 2014
  • DOI: 10.5812/hepatmon.17812

To Cite: Afzal M S, Zaidi N U S S, Dubuisson J, Rouille Y. Hepatitis C Virus Capsid Protein and Intracellular Lipids Interplay and itsAssociation With Hepatic Steatosis, Hepat Mon. 2014 ;14(8):e17812. doi: 10.5812/hepatmon.17812.

Abstract
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16): 1221-31[DOI][PubMed]
  • 2. Patel JH, Cobbold JF, Thomas HC, Taylor-Robinson SD. Hepatitis C and hepatic steatosis. QJM. 2010; 103(5): 293-303[DOI][PubMed]
  • 3. Hwang SJ, Luo JC, Chu CW, Lai CR, Lu CL, Tsay SH, et al. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. J Gastroenterol Hepatol. 2001; 16(2): 190-5[PubMed]
  • 4. Rubbia-Brandt L, Fabris P, Paganin S, Leandro G, Male PJ, Giostra E, et al. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut. 2004; 53(3): 406-12[PubMed]
  • 5. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology. 2001; 33(6): 1358-64[DOI][PubMed]
  • 6. Mirandola S, Bowman D, Hussain MM, Alberti A. Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP). Nutr Metab (Lond). 2010; 7: 13[DOI][PubMed]
  • 7. Afzal MS, Zaidi NSS, Dubuisson J, Rouillé Y. Role of HCV Capsid Protein on Cellular Lipid Droplets Content and Localization during HCV Infection. Int J Biosci Biochem Bioinforma. 2014; 4(1): 19-21
  • 8. Boulant S, Vanbelle C, Ebel C, Penin F, Lavergne JP. Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features. J Virol. 2005; 79(17): 11353-65[DOI][PubMed]
  • 9. Boulant S, Montserret R, Hope RG, Ratinier M, Targett-Adams P, Lavergne JP, et al. Structural determinants that target the hepatitis C virus core protein to lipid droplets. J Biol Chem. 2006; 281(31): 22236-47[DOI][PubMed]
  • 10. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol. 2007; 9(9): 1089-97[DOI][PubMed]
  • 11. McLauchlan J, Lemberg MK, Hope G, Martoglio B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J. 2002; 21(15): 3980-8[DOI][PubMed]
  • 12. Delgrange D, Pillez A, Castelain S, Cocquerel L, Rouille Y, Dubuisson J, et al. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J Gen Virol. 2007; 88: 2495-503[DOI][PubMed]
  • 13. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 1982; 42(9): 3858-63[PubMed]
  • 14. Rouille Y, Helle F, Delgrange D, Roingeard P, Voisset C, Blanchard E, et al. Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol. 2006; 80(6): 2832-41[DOI][PubMed]
  • 15. Clement S, Pascarella S, Negro F. Hepatitis C virus infection: molecular pathways to steatosis, insulin resistance and oxidative stress. Viruses. 2009; 1(2): 126-43[DOI][PubMed]
  • 16. Boulant S, Douglas MW, Moody L, Budkowska A, Targett-Adams P, McLauchlan J. Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner. Traffic. 2008; 9(8): 1268-82[DOI][PubMed]
  • 17. Binder M, Sulaimanov N, Clausznitzer D, Schulze M, Huber CM, Lenz SM, et al. Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle. PLoS Pathog. 2013; 9(8)[DOI][PubMed]
  • 18. Matto M, Rice CM, Aroeti B, Glenn JS. Hepatitis C virus core protein associates with detergent-resistant membranes distinct from classical plasma membrane rafts. J Virol. 2004; 78(21): 12047-53[DOI][PubMed]
  • 19. Okamoto K, Mori Y, Komoda Y, Okamoto T, Okochi M, Takeda M, et al. Intramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagation. J Virol. 2008; 82(17): 8349-61[DOI][PubMed]
  • 20. Alsaleh K, Delavalle PY, Pillez A, Duverlie G, Descamps V, Rouille Y, et al. Identification of basic amino acids at the N-terminal end of the core protein that are crucial for hepatitis C virus infectivity. J Virol. 2010; 84(24): 12515-28[DOI][PubMed]
  • 21. Popescu CI, Callens N, Trinel D, Roingeard P, Moradpour D, Descamps V, et al. NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly. PLoS Pathog. 2011; 7(2)[DOI][PubMed]
  • 22. Afzal MS, Elreheem AA, Ragaa A, Wahid A. HCV Genotype 4; A Brief Review. J Gastroenterol Hepatol Res. 2014; 3(2): 968-76
  • 23. Anjum S, Ali S, Ahmad T, Afzal MS, Waheed Y, Shafi T, et al. Sequence and structural analysis of 3’ untranslated region of hepatitis C virus, genotype 3a, from pakistani isolates. Hepat Mon 2013; 13(5)
  • 24. Anjum S, Wahid A, Afzal MS, Albecka A, Alsaleh K, Ahmad T, et al. Additional glycosylation within a specific hypervariable region of subtype 3a of hepatitis C virus protects against virus neutralization. J Infect Dis 2013; 208(11): 1888-97
  • 25. Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NU, et al. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J Infect Dev Ctries. 2011; 5(6): 473-9[PubMed]
  • 26. Afzal MS, Anjum S, Zaidi NU. Effect of Functional Interleukin-10 Polymorphism on Pegylated Interferon-alpha Plus Ribavirin Therapy Response in Chronic Hepatitis C Virus Patients Infected With 3a Genotype in Pakistani Population. Hepat Mon. 2013; 13(6)[DOI][PubMed]
  • 27. Flynn JK, Sacks-Davis R, Higgs P, Aitken C, Moneer S, Suppiah V, et al. Detection of HCV-Specific IFN-gamma Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users. Hepat Mon. 2014; 14(1)[DOI][PubMed]
  • 28. Afzal MS, Ahmed T, Zaidi NU. Comparison of HCV prevalence in pakistan and iran; an insight into future. Hepat Mon 2014; 14(1)
  • 29. Afzal MS, Anjum S, Zaidi NU. Changing of HCV clade pattern in iran; the possible means for something good. Hepat Mon. 2014; 14(1)[DOI][PubMed]
  • 30. Kumar D, Farrell GC, Fung C, George J. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response. Hepatology. 2002; 36(5): 1266-72[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments